GlassScriptPhysician profile
Ali A Dabaja
NPI 1144426792
$1,424.21
in general payments reported to CMS, 2019-2025
11 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $92.98 · 2021: $254 · 2022: $142 · 2023: $22.71 · 2024: $460 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $291.00 | 2024 | |
| Ambu INC. | $281.02 | 2020-2025 | |
| Boston Scientific Corporation | $171.02 | 2022-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter |
| Coloplast Corp | $147.61 | 2019-2021 | |
| Cook Medical LLC | $136.89 | 2021 | |
| Janssen Scientific Affairs, LLC | $127.53 | 2025 | |
| Laborie Medical Technologies Corp. | $93.75 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Procept Biorobotics Corporation | $90.44 | 2022 | |
| Ethicon US, LLC | $41.46 | 2025 | Echelon; Endopath, Enseal, Harmonic |
| Abbvie INC. | $22.71 | 2023 | Botox |
| Myovant Sciences INC. | $20.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Dabaja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.